To gain further insights into how dysregulation of these miRs may play a role in endometrial cancer cells, we performed different assays to study the biological effects of the interaction between these miRs and their target Smad4 into endometrial adenocarcinoma-derived cell lines Hec1a. The gene discussed is SMAD4; the disease is endometrium adenocarcinoma.